Sanofi News - SNY

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
SMALL CAP BASIC
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Sanofi SNY NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 42.61 0.00 0.00 0.00 42.61 04:04:35
more quote information »

Recent News

Date Time Source Heading
7/23/201901:47DJNSanofi Gets Exclusive Over-The-Counter Rights to Tamiflu in..
7/18/201909:29DJNMyoKardia Accelerates Timing for Mavacamten Topline Phase 3..
7/10/201907:05DJNSanofi: FDA to Review Isatuximab for Relapsed/Refractory..
6/28/201908:03DJNCommittee Recommends Approval for Dermatitis Treatment Be..
6/26/201914:30DJNFDA Approves Sanofi, Regeneron Treatment for Chronic..
6/26/201913:30PRNUSFDA approves Dupixent® (dupilumab) for chronic..
6/21/201906:39DJNRegeneron, Sanofi Report Positive Topline Phase 2 Asthma..
6/18/201901:44DJNSanofi, Google to Develop Healthcare Innovation Lab
6/17/201913:17DJNVoyager Therapeutics Up 9%; Restructures Relationship with..
6/17/201908:49DJNVoyager Therapeutics Restructures Gene Therapy Relationship..
6/07/201914:48DJNSanofi on Track for Largest Percent Increase Since October..
6/07/201907:44DJNSanofi Shares Post Healthy Gains After New CEO News
6/07/201902:23DJNSanofi CEO Olivier Brandicourt Retires; Paul Hudson Named..
6/07/201901:50DJNSanofi Appoints New CEO
6/06/201919:12DJNSanofi Poised to Appoint Novartis' Paul Hudson as Next CEO..
5/22/201903:02DJNFrench Deal Spree Fueled By Easy Money -- WSJ
5/21/201905:59DJNFrance Goes on Deal Spree, Thanks to ECB Easy Money
5/15/201917:00PRNUSSanofi oncology pipeline targeting various cancers..
5/08/201913:12PRNUSSanofi Recognized by DiversityInc as a Top 50 Company
5/08/201908:45PRNUSSanofi Announces Licensing of Dupixent® ▼ (dupilumab) in the..
5/07/201909:39DJNEU Approves Sanofi and Regeneron's Dupixent for Severe..
5/01/201922:16DJNSanofi's Dengue Vaccine Gets FDA Approval -- Update
5/01/201919:38DJNFDA Approves Sanofi Inc.'s Dengue Vaccine
5/01/201918:35PRNUSFDA approves Dengvaxia® for the prevention of dengue in..
4/29/201911:40DJNLexicon Pharmaceuticals Up 7% After EU Approval for Diabetes..
4/29/201910:46DJNNegative Yields Deepen Along With Europe's Problems--Update
4/26/201920:29DJNFDA Approves Expanded Label for Praluent
4/26/201917:21DJNEuropean Health Regulators Approve Oral Treatment for Type 1..
4/26/201912:48DJNRegeneron, Sanofi Skin Cancer Drug Gets Warm Reception from..
4/26/201908:19DJNDrugmakers Brace for Sales to Slow in China Amid Generic..
4/26/201908:05PRNUSSanofi delivers strong Q1 2019 business EPS growth of 9.4%..
4/26/201904:52DJNSanofi Shares Rise on Strong 1Q -- Update
4/26/201902:05DJNSanofi Posts Rises in 1Q Sales, Net Profit
4/17/201910:11PRNUSSanofi Named One of America's Best Employers by Forbes
4/17/201907:00PRNUSWorld Hemophilia Day: Sanofi Genzyme Donation Impacts..
4/11/201914:50PRNCASanté Canada émet un Avis de conformité avec conditions..
4/11/201914:43PRNCAHealth Canada issues Notice of Compliance with Conditions..
4/10/201905:00PRNUSSanofi provides unprecedented access to its insulins for one..
4/08/201901:46DJNSanofi, Alnylam Complete Research Phase of Rare Disease..
3/25/201911:20DJNLexicon Pharma Shares Down Almost 10% on FDA Rejection
3/22/201919:57DJNFDA Rejects Oral Treatment for Type 1 Diabetes - Update
3/22/201915:43DJNFDA Rejects Oral Treatment for Type 1 Diabetes
3/18/201912:21DJNSanofi Working on CEO Succession Plan -Reuters
3/11/201916:33DJNRegeneron Says FDA Approves Dupixent for Atopic Dermatitis..
3/11/201915:45PRNUSFDA approves Dupixent® (dupilumab) for moderate-to-severe..
3/08/201906:40DJNRegeneron, Sanofi Get FDA Priority Review for Dupixent
2/27/201917:56DJNFDA Allows Expanded Use for Sanofi's Soliqua
2/27/201916:17PRNUSFDA expands indication for Soliqua® 100/33
2/25/201918:22DJNAmgen Says Delaware Jury Upholds Co's Patents On Repatha
2/25/201913:40DJNSanofi Reports Positive Results in Phase 3 Trials of..
See more news about this stock »


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.